(Q43265564)

17 November 2017

title

Haploidentical hematopoietic stem-cell transplantation for non-Hodgkin lymphoma with bone marrow involvement (English)

1 reference

17 November 2017

1 reference

Heng-Xiang Wang

1

1 reference

17 November 2017

Hong-Min Yan

2

1 reference

17 November 2017

Jing Liu

3

1 reference

17 November 2017

Lian-Ning Duan

4

1 reference

17 November 2017

Zhi-Dong Wang

5

1 reference

17 November 2017

Ling Zhu

6

1 reference

17 November 2017

Mei Xue

7

1 reference

17 November 2017

Zi-Kuan Guo

8

1 reference

17 November 2017

language of work or name

1 reference

1 September 2009

1 reference

17 November 2017

1 reference

17 November 2017

volume

50

1 reference

17 November 2017

issue

9

1 reference

17 November 2017

page(s)

1488-1493

1 reference

Allogeneic transplantation in lymphoma: current status

17 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10428190903156745

Allogeneic hematopoietic cell transplantation for Hodgkin lymphoma: a concise review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190903156745

Hematopoietic cell transplantation in non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190903156745

Intensive chemotherapy followed by hematopoietic stem-cell rescue for refractory and recurrent primary CNS and intraocular lymphoma: Société Française de Greffe de Moëlle Osseuse-Thérapie Cellulaire.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190903156745

Clinico-pathologic features and outcome of Japanese patients with peripheral T-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190903156745

Allogeneic or autologous stem cell transplantation (SCT) for relapsed and refractory Hodgkin's disease and non-Hodgkin's lymphoma: a single-centre experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190903156745

Prolonged survival of patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation: the GELTAMO experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190903156745

Concordant but not discordant bone marrow involvement in diffuse large B-cell lymphoma predicts a poor clinical outcome independent of the International Prognostic Index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190903156745

Primary therapy for adults with T-cell lymphoblastic lymphoma with hematopoietic stem-cell transplantation results in favorable outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190903156745

Anti-CD25 monoclonal antibody (basiliximab) for prevention of graft-versus-host disease after haploidentical bone marrow transplantation for hematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190903156745

G-CSF-primed haploidentical marrow transplantation without ex vivo T cell depletion: an excellent alternative for high-risk leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190903156745

Haploidentical hematopoietic stem cell transplantation in child hematologic malignancies with G-CSF-mobilized marrow grafts without T-cell depletion: a single-center report of 45 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190903156745

Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190903156745

Long-term results of autologous hematopoietic cell transplantation for peripheral T cell lymphoma: the Stanford experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190903156745

Long-term results favor allogeneic over autologous hematopoietic stem cell transplantation in patients with refractory or recurrent indolent non-Hodgkin's lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190903156745

Peripheral blood stem cell contamination in mantle cell non-Hodgkin lymphoma: the case for purging?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190903156745

Allogeneic transplants in follicular lymphoma: higher risk of disease progression after reduced-intensity compared to myeloablative conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190903156745

Granulocyte-colony-stimulating factor (G-CSF)-primed allogeneic bone marrow: significantly less graft-versus-host disease and comparable engraftment to G-CSF-mobilized peripheral blood stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190903156745

Polyclonal rabbit antithymocyte globulin exhibits consistent immunosuppressive capabilities beyond cell depletion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190903156745

Rabbit ATG but not horse ATG promotes expansion of functional CD4+CD25highFOXP3+ regulatory T cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190903156745

Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190903156745

Guillain-Barré syndrome after transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190903156745

Transplantation of anergic histoincompatible bone marrow allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190903156745

Intensive Chemotherapy with Hematopoietic Cell Transplantation after ESHAP Therapy for Relapsed or Refractory Non-Hodgkin's Lymphoma. Results of a Single-Centre Study of 65 Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190903156745

10.1080/10428190903156745

21 January 2018

Identifiers

DOI

1 reference

17 November 2017

1 reference